FDA Investigator Pamela L Velez Vega
Pamela L Velez Vega has conducted inspections on 197 sites in 4 countries as of 25 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
197
Last Inspection Date:
25 Jun 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
Poland,
Latvia,
Czechia
FDA Investigators that have inspected at least one site in common with Pamela L Velez Vega:
Adree N Anderson,
Amanda L Evanco,
Amy H Ruble,
Anthony R Bucks,
April K Hill,
Audrey N Vigil,
Barbara I Rogolsky,
Blondell W Johnson,
Bonnie E Pierson,
Brandy D Brown,
Brent T Hall,
Brentley S Collins,
Brian A Graves,
Brian R Cronenwett,
Cara M Minelli,
Carl A Huffman, III,
Carl E Lovrich,
Carl J Montgomery,
Carmen Y Fisher,
Chris A Sack,
Claudele S Razo,
Claudette D Brooks,
Cody D Rickman,
Cordelia J Brammer,
Cynthia L Evitt,
Darrah,
David K Glasgow,
David L Miser,
Dawn C Olenjack,
Deborah S Hammond,
Debra J Tucker,
Decarlos A Gomez,
Dellarese L Herbert,
Devaughn Edwards,
Dewayne E Whitlock,
Diane Hall,
Doretha M Tonkins,
Doretha M Wilson,
Dr. Abhijit Raha, PhD,
Dustin K Hampton,
Edward Deberry,
Edward E Lockwood (EEL),
Eileen J Bannerman,
Elmina E Mboh,
Eric C Nielsen,
Eric M Mueller, PharmD,
Eric M Padgett,
Eric T Huebler,
Erika V Butler,
Ernest H Blackwood,
Esra Toussaint,
Esther A Ofori,
Farhana Khan,
Gene R Gunn,
George Ivan Wey,
Gloria J Champagne,
Gwyn G Dickinson,
Heather Akleimola Hulbert,
Helen R Bester,
Hristu B Chepa,
Ingrid Y Johnson,
James C Maclaughlin,
James D Planchon,
James I Giefer,
James R Fleckenstein,
Jane E Nelson,
Jeffery A Hangartner,
Jeffery L Sumter,
Jeffrey B Moody,
Jessica E Hensley,
Jessica Fields,
Jessica L Peterson,
Joanne M Schlossin,
John A Iwen,
John Dan,
Johnson,
Jonathan R Campos,
Joseph R Lambert,
Jyoti B Patel, PhD,
Kara L Roden,
Karen C Daugherty,
Karen M Montgomery (KMM),
Kathleen B Swat,
Kelly D Sheppard,
Kenneth L Smalls,
Kimberly Cdelk Brooks,
Kip J Hanks,
Kristi M Hampton Thurston,
Latonya M Mitchell,
LCDR Ismael Olvera, IV,
Leslie W Gilbert,
Linda R Kuchenthal,
Linhart,
Lisa L Flores,
Lori A Gioia,
Marion D Wimberly, Jr,
Marla A Cassidy,
Mary Alice Papadimitriou,
Mary K Concannon,
Matthew H Hunt,
Matthew M Schuckmann,
Megan M Jekel,
Michael A Blaine,
Michael F Skelly, PhD,
Michele L Obert,
Michele Perry Williams,
Michelle D Haamid,
Mindy M Chou,
Mohsen Rajabi Abhari, FDA,
Monique M Brooks,
Nancy E Fontaine,
Nancy G Schmidt,
Nancy P Hamburg,
Nicholas M Smith,
Nilufer M Tampal, PhD,
Patrick L Wisor,
Paula J Bretz,
Philip J Boston,
Randy L Clarida,
Reggie D Cope,
Richard L Garcia,
Robert J Ham,
Robert J Nesselhauf,
Rodney D Combs,
Russell R Zablan,
Shafiq S Ahadi,
Shanna R Haden,
Sharon K Thoma, PharmD,
Shaun M Olson,
Sheri L Stephenson,
Sherry G Bous,
Shirley J Berryman,
Shusheen A Alexander,
Stardust W Mazzariello,
Steven D Kehoe,
Stroman,
Susanna E Ford,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Tracy R Ball,
Valeria A Moore,
Vickie J Kanion,
Vincent M Williams,
Walsworth,
Wayne D Mcgrath,
William C Corley,
William F Lagud, Jr,
Xikui Chen (nmi), PhD,
Yiyue Zhang (nmi), PhD,
Zoey A Trombley
Pamela L Velez Vega's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2003 | FDA 483 | Washington Univ School Of Med - Form 483, 2003-08-27 |
June, 2002 | EIR | Daleco Inc - EIR, 2002-06-18 |
September, 2001 | EIR | Medical Solutions - EIR, 2001-09-26 |
June, 2003 | EIR | Dipersio, Dr John F - EIR, 2003-06-12 |
November, 2002 | EIR | Grant, Kenneth E - EIR, 2002-11-05 |
November, 2001 | EIR | Barnes Jewish Hospital Blood Bank - EIR, 2001-11-07 |
June, 2002 | FDA 483 | Daleco Inc - Form 483, 2002-06-18 |
November, 2002 | FDA 483 | Gateway Blood Association - Form 483, 2002-11-26 |
June, 2010 | EIR | The American National Red Cross - Southern Region - EIR, 2010-06-11 |
August, 2003 | EIR | Hantler, Dr Charles - EIR, 2003-08-27 |
April, 2009 | EIR | Washington Univ School Of Medicine - EIR, 2009-04-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more